Time-Resolved Tryptophan Fluorescence as an Indicator of Alterations in Serum Proteins in Melancholic Depression


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Abstract—The goal of this work was to search for blood serum parameters that would be associated with the state of patients with mental disorders. Such indicators are needed for an objective assessment of this state versus the prevailing subjective evaluation methodologies. The kinetics of tryptophan fluorescence decay in the serum albumin fraction was compared in patients with melancholic depression (before treatment) and in healthy volunteers. Albumin fluorescence is mainly due to the tryptophan 214 residue, which is located in the immediate vicinity of the first drug-binding center of the molecule. The decay kinetics were described as a sum of three exponential functions with lifetimes τi (in the 6.5, 2.8 and 1.0 ns region) and the amplitudes Ai. The τi values were similar in both groups of individuals. In contrast, there was a significant difference between patients and controls in the A1/A3 amplitude ratio. It is suggested that the A1/A3 value can be considered as a potential marker indicating the presence or absence of melancholic depression in patients before treatment.

About the authors

T. I. Syrejshchikova

Lebedev Institute of Physics, Russian Academy of Sciences

Email: esmoline@mail.ru
Russian Federation, Moscow, 119991

N. V. Smolina

Moscow Research Institute of Psychiatry, Serbsky National Medical Research Center of Psychiatry and Addiction Psychiatry, Ministry of Health of the Russian Federation

Author for correspondence.
Email: esmoline@mail.ru
Russian Federation, Moscow, 107076

V. V. Brilliantova

Moscow Research Institute of Psychiatry, Serbsky National Medical Research Center of Psychiatry and Addiction Psychiatry, Ministry of Health of the Russian Federation

Email: esmoline@mail.ru
Russian Federation, Moscow, 107076

E. D. Syromyatnikova

Lebedev Institute of Physics, Russian Academy of Sciences

Email: esmoline@mail.ru
Russian Federation, Moscow, 119991

M. G. Uzbekov

Moscow Research Institute of Psychiatry, Serbsky National Medical Research Center of Psychiatry and Addiction Psychiatry, Ministry of Health of the Russian Federation

Email: esmoline@mail.ru
Russian Federation, Moscow, 107076

G. E. Dobretsov

Federal Research and Clinical Center of Physical Chemical Medicine, Federal Medical and Biological Agency
of the Russian Federation

Email: esmoline@mail.ru
Russian Federation, Moscow, 119435

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Pleiades Publishing, Inc.